Literature DB >> 1299209

Cardiac fibroblasts: function, regulation of gene expression, and phenotypic modulation.

M Eghbali1.   

Abstract

Cardiac fibroblasts constitute the majority of the non-myocyte cell population in the ventricular myocardium. These cells are located in the interstitium, in areas between and surrounding cardiac myocytes. Cardiac fibroblasts are responsible for the synthesis of extracellular matrix proteins such as fibrillar collagen types I and III, basement membrane type IV collagen, fibronectin, and laminin. In addition to its role in muscle development and myoblast differentiations, extracellular matrix consisting primarily of fibrillar collagen is an intricate and highly organized structure that serves to support cardiac myocytes and to maintain functional integrity of the myocardium. Balanced synthesis and degradation of this matrix is the key to normal development of cardiac muscle and perfect myocardial function. Collagen remodeling and accumulation has been demonstrated in several experimental models of cardiac hypertrophy. To gain insights into molecular and cellular mechanisms that affect cardiac fibroblast behavior, cardiac fibroblasts from rat and rabbit ventricular myocardium were cultured and the impact of neurotransmitters and growth factors such as norepinephrine and transforming growth factor--beta (TGF-beta 1), to which cardiac fibroblasts are exposed in vivo, was studied. Results of these studies, with regards to gene expression, proliferation and differentiation of cardiac fibroblasts in culture, and their biological implications are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1299209     DOI: 10.1007/978-3-642-72477-0_16

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  35 in total

1.  Photolithographically defined deposition of attachment factors as a versatile method for patterning the growth of different cell types in culture.

Authors:  Stephan Rohr; Regula Flückiger-Labrada; Jan P Kucera
Journal:  Pflugers Arch       Date:  2003-02-15       Impact factor: 3.657

2.  Cell survival signalling in heart derived myofibroblasts induced by preconditioning and bradykinin: the role of p38 MAP kinase.

Authors:  Marie Cooper; Kirsti Ytrehus
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

Review 3.  Origin of cardiac fibroblasts and the role of periostin.

Authors:  Paige Snider; Kara N Standley; Jian Wang; Mohamad Azhar; Thomas Doetschman; Simon J Conway
Journal:  Circ Res       Date:  2009-11-06       Impact factor: 17.367

4.  Effect of N-acetyl-seryl-aspartyl-lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts.

Authors:  N E Rhaleb; H Peng; P Harding; M Tayeh; M C LaPointe; O A Carretero
Journal:  Hypertension       Date:  2001-03       Impact factor: 10.190

Review 5.  Micromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regeneration.

Authors:  Jan Aam Kamps; Guido Krenning
Journal:  World J Cardiol       Date:  2016-02-26

Review 6.  Defining the Cardiac Fibroblast.

Authors:  Malina J Ivey; Michelle D Tallquist
Journal:  Circ J       Date:  2016-10-14       Impact factor: 2.993

7.  Mechanically induced potentials in atrial fibroblasts from rat hearts are sensitive to hypoxia/reoxygenation.

Authors:  Andre Kamkin; Irina Kiseleva; Kay-Dietrich Wagner; Ilja Lozinsky; Joachim Günther; Holger Scholz
Journal:  Pflugers Arch       Date:  2003-03-08       Impact factor: 3.657

Review 8.  Extracellular matrix-mediated cellular communication in the heart.

Authors:  Iñigo Valiente-Alandi; Allison E Schafer; Burns C Blaxall
Journal:  J Mol Cell Cardiol       Date:  2016-01-14       Impact factor: 5.000

9.  Nkx2.5/Csx represses myofibroblast differentiation.

Authors:  Biao Hu; Yue Ming Wu; Zhe Wu; Sem H Phan
Journal:  Am J Respir Cell Mol Biol       Date:  2009-04-24       Impact factor: 6.914

10.  Chronic hypoxia inhibits MMP-2 activation and cellular invasion in human cardiac myofibroblasts.

Authors:  Kirsten Riches; Michael E Morley; Neil A Turner; David J O'Regan; Stephen G Ball; Chris Peers; Karen E Porter
Journal:  J Mol Cell Cardiol       Date:  2009-06-11       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.